Newsroom | 12142 results

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology release its 1Q'25 earnings results on May 8 after markets closed and followed with a conference call to discuss operating results....

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the first quarter ended March 31, 2025. The Company also posted its first quarter Letter to Stockholders and corporate presentation to the “Investors” section of its website, harrow.com. The Company encourages all Harrow stockholders to review these documents, which provide additional details concerning the historical quarterly period and future expectations f...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that the Company will participate in upcoming investor conferences in May 2025. 2025 RBC Capital Markets Global Healthcare Conference Tuesday, May 20th – Wednesday, May 21st, 2025, in New York City, New York. Management will be available for one-on-one meetings throughout the conference. H.C. Wai...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that the U.S. Food and Drug Administration (FDA) has approved AVMAPKI™ FAKZYNJA™ CO-PACK (avutometinib capsules; defactinib tablets) for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who received prior systemic therapy. AVMAPKI FAKZYNJA CO-PACK is the fi...

WASHINGTON--(BUSINESS WIRE)--DIA, a global non-profit organization of life sciences professionals, will unite thousands of stakeholders to address the future of international regulatory cooperation during the DIA 2025 Global Annual Meeting from June 15-19 in Washington. As policy shifts and regulatory relationships grow more uncertain, DIA 2025 gives the global life sciences community a place to confront these changes as they're unfolding. Recent changes in international health policy have unde...

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, announced that its EN-840T Double Balloon Enteroscopy (DBE) Scope, an endoscopic imaging technology that enables access to the entire small intestine for diagnosis and therapeutic intervention, has been selected as the winner of the “Best New Endoscopy Technology Solution” award in the 9th annual MedTech Breakthrough Awards program. MedTech Breakthrou...

EASTON, Pa.--(BUSINESS WIRE)--CryoConcepts, LP, a pioneer in over-the-counter cryotherapy solutions, is excited to announce the launch of Skin Clinic — The Ultimate Skin Tag Remover, an FDA-cleared at-home treatment designed for safe and effective skin tag removal. Skin Clinic — The Ultimate Skin Tag Remover brings advanced cryogenic technology, trusted by medical professionals for over 30 years, into an easy-to-use at-home treatment. Designed for effective skin tag removal, this innovative sol...

NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AccurECGTM software platform has been selected as winner of the “Best New Technology Solution for ECG” award in the 9th annual MedTech Breakthrough Awards. The program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market. AccurECG...

PONTE VEDRA, Fla.--(BUSINESS WIRE)--Cadrenal Therapeutics Reports First-Quarter 2025 Financial Results and Provides Corporate Update...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, today announced that it will publish financial results for the first quarter 2025 and provide a business update on May 15, 2025. About Precision BioSciences, Inc. Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving life (...